Government urged to reconsider drug price cut

Published: 2011-07-25 06:59:00

Updated: 2011-07-25 06:59:00

To further stimulate research and development (R&D) in the pharmaceutical industry, the government should enhance certainty in pricing and reimbursement and adequately reward the developers of drugs with proven clinical benefits, the Korean Research based Pharmaceutical Industry Association (KRPI...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK